PMID: 20021716

Gallati S, Hess S, Galie-Wunder D, Berger-Menz E, Bohlen D
Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners.
Reprod Biomed Online. 2009 Nov;19(5):685-94., [PubMed]
Sentences
No. Mutations Sentence Comment
67 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20021716:67:174
status: NEW
view ABCC7 p.Arg117His details
In CAVD patients and azoospermic men without CAVD, respectively, the most common mutation was F508del (18.0% and 7.3%) followed by the mild mutations 5T (16.0% and 6.0%) and R117H (8.0% and 1.3%). Login to comment
69 ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:69:22
status: NEW
view ABCC7 p.Ser1235Arg details
The missense mutation S1235R was not detected in 50 alleles of CAVD patients, and was also very rarely found in classic CF patients (1/ 1164 alleles) and controls (1/192 alleles), but turned out to be the third most common mutation in azoospermic men without CAVD (3/232), in oligospermic men (3/338) and in female partners (3/140). Login to comment
81 ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:81:279
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:81:272
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:81:242
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 20021716:81:293
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Val920Met
X
ABCC7 p.Val920Met 20021716:81:286
status: NEW
view ABCC7 p.Val920Met details
ABCC7 p.Gln1352His
X
ABCC7 p.Gln1352His 20021716:81:314
status: NEW
view ABCC7 p.Gln1352His details
In 70 women whose partners had tested positive for either CFTR mutations or 5T alleles, extended screening of the CFTR gene was also performed revealing a mutation spectrum similar to that of oligospermic men including four 5T alleles, three S1235R, three F508del and one I148T, V754M, V920M, D1152H, 3905insT and Q1352H each (Table 1). Login to comment
99 ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:99:958
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:99:986
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:99:998
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:99:365
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:99:407
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:99:416
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:736
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:754
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:764
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:802
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:831
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:844
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:901
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:911
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:99:924
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 20021716:99:656
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 20021716:99:666
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 20021716:99:679
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 20021716:99:716
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 20021716:99:746
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 20021716:99:777
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Gln1352His
X
ABCC7 p.Gln1352His 20021716:99:1050
status: NEW
view ABCC7 p.Gln1352His details
ABCC7 p.Gln1352His
X
ABCC7 p.Gln1352His 20021716:99:1060
status: NEW
view ABCC7 p.Gln1352His details
ABCC7 p.Gln1352His
X
ABCC7 p.Gln1352His 20021716:99:1073
status: NEW
view ABCC7 p.Gln1352His details
ABCC7 p.Ser13Tyr
X
ABCC7 p.Ser13Tyr 20021716:99:326
status: NEW
view ABCC7 p.Ser13Tyr details
ABCC7 p.Ser13Tyr
X
ABCC7 p.Ser13Tyr 20021716:99:351
status: NEW
view ABCC7 p.Ser13Tyr details
Couple no. Infertile male CFTR mutation Female partner CFTR mutation Offspring genotype Risk for genotype (%) 01 F508del/wt azoospermia F508del/wt F508del/ F508del 25 F508del/wt 50 wt/wt 25 02 F508del/T5 CAVD F508del/wt F508del/ F508del 25 F508del/T5 25 F508del/wt 25 T5/wt 25 03 F508del/S13Ya azoospermia T5/wt F508del/T5 25 S13Y/T5 25 F508del/wt 25 S13Y/wt 25 04 I148T/wt oligospermia F508del/wt F508del/ I148T 25 I148T/wt 25 F508del/wt 25 wt/wt 25 05 1717À1G>A/wt oligospermia T5/wt 1717À1G>A/ T5 25 1717À1G>A/ wt 25 T5/wt 25 wt/wt 25 06 T5/wt oligospermia 3905insT/wt 3905insT/T5 25 3905insT/wt 25 T5/wt 25 wt/wt 25 07 T5/wt azoospermia D1152H/wt D1152H/T5 25 D1152H/wt 25 T5/wt 25 wt/wt 25 08 T5/F1052V oligospermia S1235R/wt F1052V/ S1235R 25 S1235R/T5 25 F1052V/wt 25 T5/wt 25 09 S1235R/wt oligospermia T5/wt S1235R/T5 25 S1235R/wt 25 T5/wt 25 wt/wt 25 10, 11 T5/wt oligospermia S1235R/wt S1235R/T5 25 S1235R/wt 25 T5/wt 25 wt/wt 25 12 V754M/wt oligospermia T5/wt V754M/T5 25 V754M/wt 25 T5/wt 25 wt/wt 25 13 T5/wt oligospermia Q1352H/wt Q1352H/T5 25 Q1352H/wt 25 T5/wt 25 wt/wt 25 (continued on next page)(continued) female partner is a carrier. Login to comment
113 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20021716:113:149
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 20021716:113:75
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 20021716:113:216
status: NEW
view ABCC7 p.Ser1235Arg details
The three most common mutations are F508del (65.00%), 3905insT (4.81%) and R553X (3.78%) in the CF patient cohort, F508del (18.00%), 5T (16.00%) and R117H (8.00%) in CAVD patients and 5T (4.56%), F508del (3.68%) and S1235R (1.05%) in infertile non-CAVD men, exemplifying the disease specificity of the mutation patterns illustrated in Table 1. Login to comment
117 ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:117:679
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:117:701
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:117:710
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:117:716
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Val754Met
X
ABCC7 p.Val754Met 20021716:117:725
status: NEW
view ABCC7 p.Val754Met details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:117:621
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:117:635
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20021716:117:655
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:522
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:552
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:566
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:601
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:630
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 20021716:117:644
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Val920Met
X
ABCC7 p.Val920Met 20021716:117:543
status: NEW
view ABCC7 p.Val920Met details
ABCC7 p.Val920Met
X
ABCC7 p.Val920Met 20021716:117:557
status: NEW
view ABCC7 p.Val920Met details
ABCC7 p.Val920Met
X
ABCC7 p.Val920Met 20021716:117:577
status: NEW
view ABCC7 p.Val920Met details
Based on discriminant analysis, this study predicts a high probability for the presence of CFTR mutations especially in patients with reduced ejaculate volumes (<3 ml) and structural abnormalities such as CAVD, inguinal hernia, hypotrophic testes or cryptorchidism, confirming former findings reported by Casals et al. (2000) and representing symptoms that are also frequently observed in Table 3 (continued) Couple no. Infertile male CFTR mutation Female partner CFTR mutation Offspring genotype Risk for genotype (%) 14 R31C/wt oligospermia V920M/wt R31C/V920M 25 R31C/wt 25 V920M/wt 25 wt/wt 25 15 R31C/wt azoospermia I148T/wt R31C/I148T 25 R31C/wt 25 I148T/wt 25 wt/wt 25 16 V754M/wt oligospermia V754M/wt V754M/V754M 25 V754M/wt 50 wt/wt 25 Bold = mutations associated with classic cystic fibrosis; italic = mutations associated with a mild or uncertain, unpredictable phenotype; CAVD = congenital absence of the vas deferens; wt = wildtype allele. Login to comment